Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

The first evidence that removing amyloid plaques may delay Alzheimer’s symptoms has now been published. In The Lancet Neurology on March 19, scientists led by Randall Bateman at Washington University ...

This is the 59th instalment in a series on dementia, including the research into its causes and treatment ... Today we know these as amyloid plaques, which, along with tau tangles – the build ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

Though Alzheimer's disease is often described as a buildup of proteins in the brain in the form of plaques and tangles, a new ...

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...